News

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
Neurosurgeon Edward Chang, MD, developmental geneticist Thomas Kornberg, PhD, and virologist Raul Andino-Pavlovsky, PhD, have ...
It's not quite as bad as The Last of Us. But progress has been achingly slow in developing new antifungal vaccines and drugs.
Neda Safarzadeh Safarzadeh; Vice President and Head of Investor Relations, Public Relations and Marketing; Arcturus Therapeutics Holdings Inc. Joseph Payne; Presiden ...
From the anti-vaccine movement and COVID denialism to the promotion of raw pet food, the wellness-industrial complex has ...
The single-celled parasite Entamoeba histolytica infects 50 million people each year, killing nearly 70,000. Usually, this wily, shape-shifting amoeba causes nothing worse than diarrhea.
Good afternoon, everyone, and welcome to the Maravai LifeSciences Q1 2025 Results Earnings Call. [Operator Instructions] Also, today's call is being recorded. [Operator Instructions] At this time, ...
Understanding how E. histolytica attacks human cells and evades immunity is crucial for developing effective treatments and ...
“You could see little parts of the human cell being broken off,” Ralston said of her very first encounter with the parasite.
The single-celled parasite Entamoeba histolytica infects 50 million people each year, killing nearly 70,000. Usually, this ...
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators ...